The effect of magnesium in post-CABG arrhythmias

Phase 2

• Conditions: Condition 1: Ventricular premature depolarization. Condition 2: Atrial fibrillation.; Ventricular premature depolarization; Atrial fibrillation and flutter

• Registration Number: IRCT2015092224133N1
• Lead Sponsor: Ardabil University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

Inclusion :1- All patients candidate elective CABG surgery Cardiac Surgery
2-Primary blood levels of magnesium

exclusion : death in the CABG surgery or during the 12 hours after surgery

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cardiac arrhythmia. Timepoint: 3 days after surgery. Method of measurement: Electrocardiogram.

Secondary Outcome Measures

Name	Time	Method
Blood levels of magnesium. Timepoint: daily for 3 day. Method of measurement: Milligrams per deciliter by arterial blood samples.